Biocon, Mylan win patent rights for Insulin Glargine Device against Sanofi Medical Dialogues Bureau12 March 2020 11:29 AM ISTInsulin Glargine is a long-acting insulin used to treat adults with Type 2 diabetes and adults and paediatric patients with Type 1 diabetes for the...
Sun Pharma launches RIOMET ER diabetes drug in the US Medical Dialogues Bureau27 Feb 2020 4:30 PM ISTRiomet ER™, dosed once daily, is the first and only FDA-approved liquid formulation of extended-release metformin.
Akcea, Ionis report positive phase 2 study results of AKCEA-ANGPTL3-LRx MD bureau2 Feb 2020 10:30 AM ISTBoston: Akcea Therapeutics, Inc., a majority-owned affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. recently announced...
Drugmajors slash prices by 53pc for China bulk-buy program eligibility Medical Dialogues Bureau20 Jan 2020 10:00 AM ISTBeijing: Global pharmaceutical majors and generic drugmakers chopped by 53% on average prices of some of their off-patent products in the latest...
Zydus Cadila unveils affordable anti-diabetic drug Vildagliptin under brands Vinglyn, Vinglyn M Medical Dialogues Bureau12 Dec 2019 11:53 AM ISTAhmedabad: With the Novartis Blockbuster Vildagliptin going off patent, Zydus Cadila has taken made its move towards affordable diabetes care in India...
Roche secures CE Mark for Accu-Chek SugarView app for diabetes management Farhat Nasim10 Dec 2019 1:07 PM ISTNow officially classified as in-vitro diagnostics (IVD) software, the app will be made widely accessible by Roche first for certain smartphone models...
AstraZeneca sells European rights for schizophrenia drug Seroquel, Seroquel XR for USD 178 million Farhat Nasim30 Oct 2019 5:25 PM ISTThe treatment, Seroquel, and another version, Seroquel XR, have lost patent protection in Europe and Russia, AstraZeneca said. The drug variants are...
Abbott, Tandem Diabetes Care explore integrated solutions to improve diabetes management Farhat Nasim16 Oct 2019 9:40 AM ISTNew Delhi: Abbott and Tandem Diabetes Care recently announced that they intend to develop and commercialize integrated diabetes solutions that combine...
Morepen Labs adds blockbuster Rivaroxaban, Vildagliptin, UDCA to API portfolio Farhat Nasim14 Oct 2019 1:36 PM ISTWhile two products Rivaroxaban and Vildagliptin will augment Morepen Lab's presence in the cardiac and diabetic segments respectively, the third...
Sub-committee to align Drugs And Cosmetics, Magical Remedies Act to regulate Medical Advertisements: CDSCO Committee Farhat Nasim2 Oct 2019 11:48 AM ISTNew Delhi: The Drug Consultative Committee (DCC), functional under the apex drug regulatory body, Central Drug Standard Control Organisation (CDSCO)...
Novo Nordisk Tresiba shows lower risk of hypo in adults with Type 2 Diabetes Medical Dialogues Bureau21 Sept 2019 9:30 AM IST"We are delighted that the findings of the CONCLUDE trial support what we have seen previously across the Tresiba clinical development programme,"...
Medtronic, Novo Nordisk team up for integrating glucose monitoring, insulin dosing data to help diabetics Medical Dialogues Bureau18 Sept 2019 9:30 AM ISTThis new, non-exclusive collaboration reflects both Medtronic plc and Novo Nordisk commitment to make diabetes management easier by integrating key...
